Article 2 Interpretation
In this Order—
-
“2012 Regulations” means the Human Medicines Regulations 2012f1;
-
“approved UK prescriber” means an authorised prescriber who is an appropriate practitioner in relation to any prescription only medicine by virtue of regulation 214(3)(a), (c), (d) or (e) of the 2012 Regulationsf2 (sale or supply of prescription only medicines);
-
“authorised prescriber” means any person who is an appropriate practitioner for the purposes of regulation 214 of the 2012 Regulations (subject to any limits on their prescribing rights included in that regulation);
-
“clinical trial” has the meaning given in regulation 2(1) of the Medicines for Human Use (Clinical Trials) Regulations 2004f3 (interpretation);
-
“current national identity document” means a document that is a current national identity document for the purposes of the rules under section 3(2) of the Immigration Act 1971f4 (general provisions for regulation and control);
-
“gonadotrophin-releasing hormone analogue” or “GnRH analogue” means a medicinal product that consists of or contains buserelin, gonadorelin, goserelin, leuprorelin acetate, nafarelin or triptorelin;
-
“licensing authority” has the meaning given in regulation 6(2) of the 2012 Regulationsf5 (the licensing authority and the Ministers);
-
“NHS prescription” means an order for a medicinal product which is in the form of a prescription or direction and which is issued by an authorised prescriber as part of arrangements for the provision of services as part of—
- (a)
in England, the health service as defined by section 275(1) of the National Health Service Act 2006f6 (interpretation);
- (b)
in Scotland, the health service as defined by section 108(1) of the National Health Service (Scotland) Act 1978f7 (interpretation and construction);
- (c)
in Wales, the health service as defined by section 206(1) of the National Health Service (Wales) Act 2006f8 (interpretation);
- (d)
in Northern Ireland, the system of health and social care promoted under section 2(1) of the Health and Social Care (Reform) Act (Northern Ireland) 2009f9 (Department’s general duty);
- (a)
-
“private prescription” means an order for a medicinal product which is in the form of a prescription or direction which is not a NHS prescription (whether or not it would otherwise be considered a private prescription);
-
“sale” means sale by retail (and “selling” has a corresponding meaning);
-
“specified document” has the meaning given in rule 37(1H) of the election rules in Schedule 1 to the Representation of the People Act 1983f10 (Parliamentary election rules – voting procedure and voter identification requirements);
-
“standard private prescription” means a private prescription which—
- (a)
is a prescription rather than a direction; and
- (b)
is or purports to be in accordance with the requirements of regulation 217, 218, 219 or 219A of the 2012 Regulationsf11 (which relate to requirements for paper and electronic prescriptions);
- (a)
-
“UK birth certificate” means a certified copy of a United Kingdom birth register entry or a valid certificate of birth compiled from such an entry.
For the purposes of this Order, treatment is treatment in respect of gender dysphoria, gender incongruence or a combination or both if it is, viewed objectively, treatment in respect of those conditions, as gender dysphoria and gender incongruence are ordinarily understood as part of medical practice in the United Kingdom.
Annotations
Footnotes
- f1
-
S.I. 2012/1916, as amended.
- f2
-
Regulation 214 has been amended by S.I. 2013/1855, 2014/490, 2016/186, 2018/199 and 2019/775.
- f3
-
S.I. 2004/1031. There have been amendments to regulation 2(1) but none of them are relevant.
- f4
- f5
-
There have been amendments to regulation 6, but none are relevant. As a consequence of the renaming of the Department of Health, Social Services and Public Safety as the Department of Health by the Departments Act (Northern Ireland) 2016 (c. 5 (N.I.)), section 1(5), the powers of the Minister for Health, Social Services and Public Safety are now exercised by the Minister of Health.
- f6
-
2006 c. 41. There have been amendments to section 275(1), but none of them are relevant.
- f7
-
1978 c. 29. There have been amendments to section 108(1), but none of them are relevant.
- f8
-
2006 c. 42. There have been amendments to section 206(1), but none of them are relevant.
- f9
- f10
-
1983 c. 2. Paragraph (1H) was inserted by the Elections Act 2022 (c. 37), Schedule 1, paragraph 18(4).
- f11
-
Regulation 217 has been amended by S.I. 2014/490 and 2019/775. Regulation 218 has been amended by S.I. 2014/490 and 1878, 2015/903 and 2019/775. Regulation 219 has been amended by S.I. 2015/903, 2016/696, 2019/775 and 2023/98. Regulation 219A was inserted by S.I. 2015/903 and amended by S.I. 2019/775.